share_log

Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

SEC ·  Aug 9 04:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more